SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-21-000064
Filing Date
2021-11-09
Accepted
2021-11-08 18:33:39
Documents
98
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20210930x10q.htm   iXBRL 10-Q 3154632
2 EX-10.1 amph-20210930ex101bcc443.htm EX-10.1 1654091
3 EX-10.2 amph-20210930ex10261602f.htm EX-10.2 235928
4 EX-31.1 amph-20210930ex3112cadb3.htm EX-31.1 18650
5 EX-31.2 amph-20210930ex31206abae.htm EX-31.2 18305
6 EX-32.1 amph-20210930ex321a957ea.htm EX-32.1 9575
7 EX-32.2 amph-20210930ex3220ad2cc.htm EX-32.2 9576
8 GRAPHIC amph-20210930ex101bcc443001.jpg GRAPHIC 61252
  Complete submission text file 0001297184-21-000064.txt   14311406

Data Files

Seq Description Document Type Size
9 EX-101.SCH amph-20210930.xsd EX-101.SCH 68756
10 EX-101.CAL amph-20210930_cal.xml EX-101.CAL 67312
11 EX-101.DEF amph-20210930_def.xml EX-101.DEF 269792
12 EX-101.LAB amph-20210930_lab.xml EX-101.LAB 537765
13 EX-101.PRE amph-20210930_pre.xml EX-101.PRE 492205
14 EXTRACTED XBRL INSTANCE DOCUMENT amph-20210930x10q_htm.xml XML 2593655
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 211389288
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences